Diabetes, Obesity and COVID-19 Webinar, 18:00-19:30, 25 June 2020.

The recording of the webinar is available here


Confirmed speakers and panelists include:

The full programme can be viewed here

Novo Nordisk has provided sponsorship to the Association for the Study of Obesity (ASO) to fully fund all costs for the development of this webinar, including creation, organisation, production and administration. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ASO.